Search Results Search Sort by RelevanceMost Recent Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411. Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor. 2004;6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411. In the Literature Nov 2004 Determining Research through Underdetermined Treatment Abraham P. Schwab, PhD Paul Miller and Charles Weijer defend the concept of equipoise in medical research in a recent journal article. Virtual Mentor. 2004;6(11):488-489. doi: 10.1001/virtualmentor.2004.6.11.jdsc1-0411. Case and Commentary Dec 2004 Preoperative Screening: Medical or Legal Guidelines? Commentary 2 Erin Egan, MD, JD Clinical judgment and experience often trump evidence-based practice guidelines in physicians' medical decision-making process. Virtual Mentor. 2004;6(12):544-546. doi: 10.1001/virtualmentor.2004.6.12.ccas3-0412. State of the Art and Science Dec 2004 The Impact of Recent Clinical Trials on National Cholesterol Education Program Adult Treatment Panel III Guidelines Niharika P. Bansal Recent clinical trials have led to updates in the management of patients with high cholesterol. Virtual Mentor. 2004;6(12):550-553. doi: 10.1001/virtualmentor.2004.6.12.cprl1-0412. Case and Commentary Dec 2004 Preoperative Screening: Medical or Legal Guidelines? Commentary 1 Mark Tonelli, MD, MA Clinical judgment and experience often trump evidence-based practice guidelines in physicians' medical decision-making process. Virtual Mentor. 2004;6(12):542-544. doi: 10.1001/virtualmentor.2004.6.12.ccas3-0412. Pagination First page « First Previous page ‹ Previous … Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Current page 19
Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411.
Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor. 2004;6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411.
In the Literature Nov 2004 Determining Research through Underdetermined Treatment Abraham P. Schwab, PhD Paul Miller and Charles Weijer defend the concept of equipoise in medical research in a recent journal article. Virtual Mentor. 2004;6(11):488-489. doi: 10.1001/virtualmentor.2004.6.11.jdsc1-0411.
Case and Commentary Dec 2004 Preoperative Screening: Medical or Legal Guidelines? Commentary 2 Erin Egan, MD, JD Clinical judgment and experience often trump evidence-based practice guidelines in physicians' medical decision-making process. Virtual Mentor. 2004;6(12):544-546. doi: 10.1001/virtualmentor.2004.6.12.ccas3-0412.
State of the Art and Science Dec 2004 The Impact of Recent Clinical Trials on National Cholesterol Education Program Adult Treatment Panel III Guidelines Niharika P. Bansal Recent clinical trials have led to updates in the management of patients with high cholesterol. Virtual Mentor. 2004;6(12):550-553. doi: 10.1001/virtualmentor.2004.6.12.cprl1-0412.
Case and Commentary Dec 2004 Preoperative Screening: Medical or Legal Guidelines? Commentary 1 Mark Tonelli, MD, MA Clinical judgment and experience often trump evidence-based practice guidelines in physicians' medical decision-making process. Virtual Mentor. 2004;6(12):542-544. doi: 10.1001/virtualmentor.2004.6.12.ccas3-0412.